Overview
Squamous cell carcinoma of the rectum (also called rectal squamous cell carcinoma or SCC of the rectum) is a very rare type of cancer that starts in the rectum — the last section of the large intestine, just before the anus. Unlike the much more common rectal adenocarcinoma, which grows from gland cells, this cancer grows from flat, scale-like cells called squamous cells. These cells are not normally found in the rectum in large numbers, which is part of why this cancer is so unusual. The cancer can cause symptoms similar to other rectal cancers, including rectal bleeding, changes in bowel habits, pain or pressure in the lower abdomen or rectum, and a feeling that the bowel does not fully empty. Because it is so rare, it is often mistaken for more common rectal cancers or for anal squamous cell carcinoma, which can delay diagnosis. Treatment usually involves a combination of radiation therapy and chemotherapy (called chemoradiation), sometimes followed by surgery to remove the tumor. The approach is often borrowed from treatment strategies used for anal squamous cell carcinoma, since both share the same cell type. Early detection gives the best chance of successful treatment, but because this cancer is so rare, there are no large clinical trials specifically designed for it, and treatment decisions are often made on a case-by-case basis.
Also known as:
Key symptoms:
Rectal bleeding or blood in the stoolChanges in bowel habits, such as diarrhea or constipationFeeling that the bowel does not fully empty after a bowel movementPain or pressure in the lower abdomen or rectumNarrow or pencil-thin stoolsUnexplained weight lossFatigue or tiredness without a clear causeA lump or mass that can be felt in or near the rectumMucus in the stoolAnal or rectal pain, especially during bowel movements
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
10 eventsSixth Affiliated Hospital, Sun Yat-sen University — PHASE2
University Health Network, Toronto — PHASE2
National Cancer Institute, Naples
Latin American Cooperative Oncology Group
Centre Hospitalier Universitaire de Besancon — PHASE2
Centre Hospitalier Universitaire de Besancon — PHASE2
Umeå University — NA
Brigham and Women's Hospital — PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableBavencio
BAVENCIO is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma (UC) who have disease progression during or following platinum-containing chemotherapy or h…
BAVENCIO is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma (UC) who have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
2 resourcesOPDIVO
E.R. Squibb & Sons, L.L.C.
OPDIVO — Contact E.R. Squibb & Sons, L.L.C.
Travel Grants
No travel grants are currently matched to Squamous cell carcinoma of the rectum.
Community
No community posts yet. Be the first to share your experience with Squamous cell carcinoma of the rectum.
Start the conversation →Latest news about Squamous cell carcinoma of the rectum
Disease timeline:
New recruiting trial: Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA
A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum
New recruiting trial: MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach
A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum
New recruiting trial: Proton Versus Photon Therapy in Anal Squamous Cell Carcinoma
A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum
New recruiting trial: Adaptive Radiation in Anal Cancer
A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum
New recruiting trial: Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer
A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum
New recruiting trial: High Resolution Anuscopy Study
A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum
New recruiting trial: A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection
A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum
New recruiting trial: A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum
New recruiting trial: Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum
New recruiting trial: Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.
A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What stage is my cancer, and has it spread beyond the rectum?,Should my tumor be tested for HPV or other markers that might affect my treatment?,Is chemoradiation the right first step for me, or should surgery be considered?,Are there any clinical trials I might be eligible for given how rare this cancer is?,What are the chances that treatment will result in complete remission?,Should I be referred to a major cancer center that specializes in rare gastrointestinal cancers?,What long-term side effects should I expect from treatment, and how can they be managed?
Common questions about Squamous cell carcinoma of the rectum
What is Squamous cell carcinoma of the rectum?
Squamous cell carcinoma of the rectum (also called rectal squamous cell carcinoma or SCC of the rectum) is a very rare type of cancer that starts in the rectum — the last section of the large intestine, just before the anus. Unlike the much more common rectal adenocarcinoma, which grows from gland cells, this cancer grows from flat, scale-like cells called squamous cells. These cells are not normally found in the rectum in large numbers, which is part of why this cancer is so unusual. The cancer can cause symptoms similar to other rectal cancers, including rectal bleeding, changes in bowel ha
How is Squamous cell carcinoma of the rectum inherited?
Squamous cell carcinoma of the rectum follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Squamous cell carcinoma of the rectum typically begin?
Typical onset of Squamous cell carcinoma of the rectum is adult. Age of onset can vary across affected individuals.
Are there clinical trials for Squamous cell carcinoma of the rectum?
Yes — 1 recruiting clinical trial is currently listed for Squamous cell carcinoma of the rectum on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Squamous cell carcinoma of the rectum?
25 specialists and care centers treating Squamous cell carcinoma of the rectum are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Squamous cell carcinoma of the rectum?
2 patient support programs are currently tracked on UniteRare for Squamous cell carcinoma of the rectum. See the treatments and support programs sections for copay assistance, eligibility, and contact details.